Xolamid 1% (Ophthalmic Suspension)
5 ml drop: ৳ 501.50
Medicine Details
Category | Details |
---|---|
Generic | Brinzolamide |
Company | Opsonin pharma ltd |
Indications
- Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma
Pharmacology
- Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion
- Reduction in intraocular pressure (IOP)
Dosage & Administration
- Shake well before use
- Insert 1 drop in the affected eye(s) three times daily
- Concomitant use with other topical ophthalmic products
- Pediatric use: 1 drop in the affected eye(s) 2 times daily (4 weeks to 5 years age)
- Geriatric use: No overall differences in safety or effectiveness observed between elderly and younger patients
Interaction
- Rare instances of drug interactions with high-dose salicylate therapy in patients treated with oral carbonic anhydrase inhibitors
Contraindications
- Hypersensitivity to any component of this product
Side Effects
- Blurred vision
- Bitter, sour, or unusual taste
- Blepharitis
- Dermatitis
- Dry eye
- Foreign body sensation
- Headache
- Hyperemia
- Ocular discharge
- Ocular discomfort
- Ocular keratitis
- Ocular pain
- Ocular pruritus
- Allergic reactions
- Alopecia
- Chest pain
- Conjunctivitis
- Dizziness
- Dry mouth
- Dyspnea
- Dyspepsia
- Eye fatigue
- Hypertonia
- Keratoconjunctivitis
- Lid margin crusting or sticky sensation
- Nausea
- Pharyngitis
- Tearing
- Urticaria
Pregnancy & Lactation
- Pregnancy Category C
- No adequate and well-controlled studies in pregnant women
- Use during pregnancy only if potential benefit justifies potential risk to the fetus
- Use only if potential benefit justifies potential risk to the baby
Precautions & Warnings
- Sulfonamide drug
- Absorbed systemically
- Adverse reactions attributable to sulfonamides may occur
- Fatalities rarely occurred due to severe reactions to sulfonamides
- Sensitization may occur upon re-administration of a sulfonamide
- Discontinue use if serious reactions or hypersensitivity occur
- Not recommended in renal impairment patients
- Use with caution in patients with hepatic impairment
Overdose Effects
- Electrolyte imbalance
- Development of an acidosis state
- Possible nervous system effects following oral administration of an overdose
- Monitor serum electrolyte levels (particularly potassium) and blood pH levels
Therapeutic Class
- Drugs for miotics and glaucoma
Storage Conditions
- Store at room temperature
- Protect from light
- Do not touch dropper tip to any surface
- Contents should not be used more than four weeks after first opening of the bottle
- Protect from freezing
Related Brands
- Azobrin 1% (Ophthalmic Suspension) - healthcare-pharmaceuticals-ltd
- Azomid 1% (Ophthalmic Suspension) - beximco-pharmaceuticals-ltd
- Brinz 1% (Ophthalmic Suspension) - osl-pharma-limited
- Azopres 1% (Ophthalmic Suspension) - ibn-sina-pharmaceuticals-ltd
- Genazopt 1% (Ophthalmic Suspension) - general-pharmaceuticals-ltd